Lifecore Biomedical (LFCR) Craig-Hallum Bioprocessing Virtual Conference summary

Company positioning and capabilities

• Operates as a sterile fill-finish organization, handling drug products after the active pharmaceutical ingredient is made.

• Functions as a fully integrated CDMO, supporting clients from preclinical through commercial manufacturing and lifecycle management.

• Provides services including stability studies, material procurement, and supply chain optimization.

Customer engagement and process

• Clients define their entry point, from preclinical to late-stage or site transfer.

• Initial technical assessment and compliance audits precede business negotiations and contract finalization.

Core products and markets

• Leading manufacturer of hyaluronic acid (HA) for sterile injectables, especially in ophthalmics, orthopedics, and aesthetics.

• Recognized as a dominant player in the injectable HA market, collaborating with major industry partners.